Risperidone in the Treatment of Psychotic DepressionMiodownik, Chanoch; Lerner, VladimirClinical Neuropharmacology: November-December 2000 - Volume 23 - Issue 6 - p 335-337 Brief Reports Buy Abstract Author InformationAuthors Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study. Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel Address correspondence and reprint requests to Vladimir Lerner, Beer-Sheva Mental Health Center, PO Box 4600, Beer-Sheva, 84170, Israel. © 2000 Lippincott Williams & Wilkins, Inc.